Osseous changes and abnormalities of mineral metabolism in daunomycin rats.
We examined whether daunomycin rats could be used as an experimental model of human chronic renal failure in terms of their osseous changes and mineral metabolism. The daunomycin rats revealed hyperphosphatemia and osteodystrophic bone changes. In this respect, they were similar to human chronic renal failure. A high calcium level was found in the daunomycin rats at first due to the effect of the daunomycin injection, but later there was a lower calcium level than in the control rats due to chronic renal failure. We conclude that daunomycin rats can be successfully used as an experimental model of chronic renal failure from the standpoint of their osseous changes and mineral metabolism.
Shimizu
K
K
Aichi Prefectural Women's Junior College, Nagoya, Japan.
Maeda
K
K
Shibata
M
M
Ise
M
M
Sugano
M
M
Uehara
Y
Y
D000818:Animals; D015519:Bone Density; D001842:Bone and Bones / Q000378:metabolism* / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D003630:Daunorubicin / Q000009:adverse effects*; D004195:Disease Models, Animal; D005260:Female; D007676:Kidney Failure, Chronic / Q000139:chemically induced* / Q000378:metabolism; D010758:Phosphorus / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D010758:Phosphorus; D002118:Calcium; D003630:Daunorubicin